Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Cash from Financing Activities (2019 - 2026)

Updated

Bright Minds Biosciences (DRUG) posted Cash from Financing Activities of $60,171 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$12,175 a year earlier and down 100.0% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Cash from Financing Activities (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Bright Minds Biosciences was $200.47 million, up 436.3% year-over-year; for FY2025 (ended Sep 30, 2025), it was $61.22 million.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 141.2% (FY2020 to FY2025).
  • In prior fiscal years, Bright Minds Biosciences' Cash from Financing Activities was $595,934 in FY2024 (-63.3%), $1.62 million in FY2023 (-60.1%), $4.07 million in FY2022 (-80.3%) and $20.62 million in FY2021.
  • Quarterly Cash from Financing Activities has run from a low of -$17,269 in fiscal Q4 2024 to a high of $166.6 million in fiscal Q2 2026 over five years.
  • According to Business Quant data, Cash from Financing Activities for the three prior fiscal quarters was $166.6 million (Q2 2026), $9.6 million (Q1 2026) and $24.21 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -8.78 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -5.05 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -47.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 2.34 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -3.66 Bn
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn - 60,170.52
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60,170.52
Mar 31, 2026 166.60 Mn
Dec 31, 2025 9.60 Mn
Sep 30, 2025 24.21 Mn
Jun 30, 2025 -12,175.29
Mar 31, 2025 157,073.13
Dec 31, 2024 37.25 Mn
Sep 30, 2024 -17,268.54
Jun 30, 2024 -16,053.65
Mar 31, 2024 -16,294.58
Dec 31, 2023 644,953.78
Sep 30, 2023 -16,145.67
Jun 30, 2023 -15,997.54
Mar 31, 2023 -15,896.07
Dec 31, 2022 1.66 Mn
Sep 30, 2022 3.88 Mn
Jun 30, 2022 9,412.09
Mar 31, 2022 1,329.48
Dec 31, 2021 93,811.99
Sep 30, 2021 -7,705.77
API Access

Bright Minds Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DRUG&period=max&api_key=YOUR_API_KEY